# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Calamity Jane (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI008-SYN
- Date: 2026-04-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ruth Ann Kessler, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Ms. Canary is a 44-year-old woman with severe alcohol use disorder in early remission on monthly extended-release naltrexone, and alcohol-associated steatotic liver disease, who comes for her yearly preventive visit four weeks after her four-week review; her second naltrexone injection is due today. She has had no alcohol since intake, eight weeks ago. She has had the urge to drink on a few evenings and called the peer recovery specialist twice. Her tooth socket has healed. She is eating two meals a day with SNAP benefits and has gained weight. She is still staying at her friend's house and is on the waiting list for a room through the housing program. She cannot remember a Pap test or a mammogram, or any vaccines as an adult. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 44 |
| Alcohol | None for eight weeks; cravings on a few evenings |
| Naltrexone | Second monthly injection due today |
| Mood | PHQ-9 7; item 9 scored 0 |
| Medicines | Extended-release naltrexone 380 mg every four weeks; thiamine 100 mg and folic acid 1 mg daily |

## Health risk assessment

Read aloud and completed with the patient by the clinic's community health worker, at her request, and reviewed with her by Dr. Kessler. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair, and better than two months ago |
| Psychosocial | Friends in town; weekly contact with the peer recovery specialist; a women's mutual-help meeting on Thursdays |
| Alcohol | None for eight weeks; AUDIT 31 at intake |
| Tobacco | Chews tobacco daily; does not smoke |
| Physical activity | Physical work most days and walking everywhere |
| Nutrition | Two meals a day on most days with SNAP benefits and the food bank |
| Sleep | Six hours, better than in the first weeks |
| Safety at home | Feels safe where she is staying; no one hurts or threatens her; her rifle is locked at her friend's house |
| Road safety | Does not drive; gets rides or walks |
| Activities of daily living | Independent |
| Hearing and vision | No difficulty |
| Oral health | One molar removed last month; a dental cleaning booked at the community health center |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or weight loss; weight rising |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | Extraction site healed |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough lasting more than two weeks, no blood in sputum |
| Gastrointestinal | Negative | No abdominal pain, vomiting, black stools or yellowing of the eyes |
| Genitourinary | Negative | Periods irregular; no abnormal bleeding or discharge |
| Musculoskeletal | Negative | Aches after heavy work only |
| Integumentary | Negative | No rash; injection site from the last dose healed |
| Neurological | Negative | No tremor, numbness or unsteadiness |
| Psychiatric | Positive | Some low days and evening cravings; PHQ-9 7; no thoughts of suicide or self-harm |

11 systems reviewed. **S**

## Current medications

- Thiamine 100 mg oral tablet, one tablet daily **S**
- Folic acid 1 mg oral tablet, one tablet daily **S**
- Extended-release naltrexone 380 mg by deep intramuscular injection into the buttock every four weeks, given by the clinic nurse **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 51.4 kg; BMI 18.9 kg/m². All vital signs are synthetic.

PHQ-9: 7; Total cholesterol: 168 mg/dL; HDL cholesterol: 72 mg/dL; LDL cholesterol (calculated): 80 mg/dL; Triglycerides: 82 mg/dL. All results are synthetic.

## Change since baseline

- PHQ-9: 14 at baseline, 7 at this visit **S**

## Immunizations given today

- Tdap vaccine; no tetanus booster she can recall **S**
- Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake **S**
- Hepatitis A vaccine, adult, first of two doses **S**
- Pneumococcal conjugate vaccine (PCV20) **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin, well; weight 51.4 kg, BMI 18.9; blood pressure 120/76; pulse 76 |
| Eyes | No scleral icterus |
| Mouth | Extraction socket healed; several other decayed teeth |
| Neck | No thyroid enlargement or nodes |
| Breasts | Examined with her consent and a chaperone present; no masses |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender; liver edge not palpable; no ascites |
| Skin | No spider angiomas or palmar erythema |
| Neurological | No tremor; gait steady |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B screening done at intake were negative, and she is not immune to hepatitis B. Lipid panel: total cholesterol 168, HDL 72, LDL 80 and triglycerides 82 mg/dL; 10-year cardiovascular risk low; no statin. She chose self-collection for the cervical screening test after the options were explained. **S**
   - HPV test on a self-collected sample today.
   - Screening mammogram ordered at the mobile unit; the community health worker will arrange transport.
   - Interferon-gamma release assay for latent tuberculosis today, since she has stayed in shelters.
   - Next preventive visit in one year.
2. **Severe alcohol use disorder in early remission on extended-release naltrexone** (F10.20). Eight weeks without alcohol. Safety reviewed: no thoughts of suicide or self-harm; the rifle remains locked at her friend's house; she carries the 988 card. **S**
   - Extended-release naltrexone 380 mg intramuscularly today; next dose in four weeks at a nurse visit.
   - Continue weekly peer recovery contact and her Thursday meeting.
3. **Chewing tobacco** (F17.220). Not ready to stop; she would like to wait until she has been sober longer. **S**
   - Nicotine lozenges offered whenever she is ready.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/76 mmHg |
| Cervical cancer screening | Completed today | No screening she can recall; HPV test on a self-collected sample today |
| Breast cancer screening | Ordered | Mammography every two years from 40; ordered at the mobile unit, with transport arranged |
| Colorectal cancer screening | Not indicated | Begins at 45, next year |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 168, HDL 72, LDL 80, triglycerides 82 mg/dL; 10-year risk low; statin not indicated |
| Diabetes screening | Not indicated | Recommended at 35 to 70 for adults with overweight or obesity; BMI 18.9 |
| HIV screening | Up to date | Negative at intake |
| Hepatitis C screening | Up to date | Antibody negative at intake |
| Hepatitis B screening | Up to date | Triple panel at intake: not infected and not immune |
| Latent tuberculosis screening | Ordered | Interferon-gamma release assay today; she has stayed in shelters |
| Intimate partner violence screening | Completed today | Negative now; past violence by a former partner, discussed only as far as she wished |
| Depression screening | Completed today | PHQ-9 7, from 14 at intake; item 9 scored 0 |
| Unhealthy alcohol use | Up to date | In treatment; no alcohol for eight weeks |
| Tobacco cessation | Declined | Chews tobacco daily; advice given and nicotine lozenges offered; she will be asked again at each visit |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today |
| Hepatitis B vaccine | Completed today | First of two HepB-CpG doses; second in one month or more |
| Hepatitis A vaccine | Completed today | First of two doses for chronic liver disease; second in six months |
| Pneumococcal vaccine | Completed today | PCV20 today; indicated by alcohol use disorder and chronic liver disease |
| Influenza vaccine | Not indicated | Season over; to be given in the autumn |
| HPV vaccine | Declined | Shared decision-making for adults 27 to 45; she chose not to have it |

## Advance care planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, the friend she is staying with, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is her independence and her friends, and that she wants to be told the truth about her health in plain words. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (American Journal of Psychiatry 2018;175(1):86-90)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Ten-week review in two weeks. HPV, tuberculosis test and mammogram results at the next visits. Second hepatitis B dose in one month or more; second hepatitis A dose in six months. Naltrexone injection at a nurse visit in four weeks. Next preventive visit in one year. **S**
- Next scheduled visit 2026-05-11: ten-week review: recovery, mood, housing and results. **S**
